effect calcium antagonist isradipin capac pulmonari function morbid surviv rate patient sever chronic obstruct pulmonari diseas copd random double-blind placebo-control studi benefici effect calcium antagonist pulmonari haemodynam patient chronic obstruct pulmonari diseas copd sever studi such effect decreas pulmonari vascular resist increas cardiac output increas oxygen deliveri clinic implic effect uncertain random double-blind placebo-control long-term studi first clinic effect calcium antagonist patient copd aim hypothesi calcium antagonist isradipin capac lung function decreas morbid mortal fifty-two patient copd observ period signific differ isradipin group placebo group regard paramet evid introduct calcium antagonist part routin treatment copd 